The two COVID-19 vaccines — Covishield and Covaxin — tested and manufactured in India by the Pune-based Serum Institute and Hyderabad-based Bharat Biotech, respectively, could have played a vital role in ending the pandemic in the country. However, the regulator’s haste and lack of transparency in approving the vaccines for “restricted” use do not inspire confidence. (Read More)
Be the first to comment